Download full-text PDF

Source

Publication Analysis

Top Keywords

thrombectomy iliofemoral
4
iliofemoral venous
4
venous thrombosis
4
thrombectomy
1
venous
1
thrombosis
1

Similar Publications

Simultaneous pancreas-kidney (SPK) transplantation is a recognized treatment for patients with insulin-dependent diabetes and advanced chronic kidney disease or end-stage renal disease (ESRD), offering significant survival benefits. However, it is associated with a higher risk of venous thrombosis, which can jeopardize the survival of the pancreaticoduodenal graft. This case report describes a patient with type 2 diabetes, hypertension, and ESRD who developed acute, occlusive deep vein thrombosis (DVT) involving the right common femoral, profunda femoral, and greater saphenous veins on postoperative day 1 (POD1) following a deceased donor SPK transplant, despite systemic prophylactic anticoagulation.

View Article and Find Full Text PDF

Objectives: Comparison of the treatment effects of immediate stent implantation vs staged stent implantation after AngioJet mechanical thrombectomy in patients with acute iliofemoral venous thrombosis.

Methods: A study included 80 patients with acute iliofemoral venous thrombosis formed between June 2021 and February 2023. They were divided into two groups: the direct implantation group (37 patients, 9 males) and the staged implantation group (43 patients, 10 males).

View Article and Find Full Text PDF
Article Synopsis
  • Iliofemoral deep venous thrombosis is linked to post-thrombotic syndrome (PTS), and two main treatments are pharmacomechanical catheter-directed thrombolysis (PCDT) and mechanical thrombectomy (MT) with large-bore devices.
  • A study analyzed 349 patients from 2007 to 2022, comparing PCDT and MT, focusing on PTS rates, vessel patency, and other outcomes, finding no significant differences in PTS rates between the two treatment groups.
  • MT patients had better logistical outcomes, including greater likelihood of a single operating room visit and shorter ICU stay, but it was not associated with increased PTS risk or higher Villalta scores.
View Article and Find Full Text PDF

Case report of simultaneous phlegmasia cerulea dolens and acute limb ischemia.

Int J Surg Case Rep

December 2024

Department of Vascular surgery, University hospital of Bratislava, Faculty of Medicine - Comenius University, Slovak Republic.

Article Synopsis
  • Phlegmasia cerulea dolens (PCD) is a serious condition caused by massive deep vein thrombosis that can threaten both life and limbs, often requiring urgent treatment options such as endovascular therapy or surgical embolectomy in specific cases.
  • A patient case illustrated simultaneous PCD with acute limb ischemia, showing symptoms like abdominal pain, cyanosis, and motor deficits, leading to a successful combined surgical embolectomy to resolve the issues.
  • This report emphasizes that there are no formal guidelines for treating PCD and stresses the necessity for personalized treatment strategies and comprehensive care access.
View Article and Find Full Text PDF

Background: Deep vein thrombosis (DVT) is a common medical condition that is associated with clinically significant sequelae, including postthrombotic syndrome (PTS). Anticoagulation alone remains the guideline-recommended treatment for many patients with iliofemoral DVT. Recent technological advances have led to an increase in the use of mechanical thrombectomy for DVT, but mechanical thrombectomy-based procedures have not yet been compared with standard-of-care anticoagulation therapy in randomized studies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!